No sure, but to get a credit would be nearly impossible. To find a new partner would be great, but which one will invest at the current stage? Further toxic funding?
I hope by heart the GENTA will find a proper way or even better a partner for at least for Tesetaxel.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.